Power Solutions (PSIX) Files Form 144 for 2,500-Share Sale on NASDAQ
Rhea-AI Filing Summary
Power Solutions International (PSIX) filed a Form 144 indicating a proposed sale of 2,500 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 08/13/2025. The filing lists an aggregate market value of $225,065.75 and shows 23,029,846 shares outstanding for the issuer, with the 2,500 shares identified for sale.
The shares were acquired on 07/10/2024 as restricted stock vesting under a registered plan and recorded as compensation. The filer reports no securities sold in the past three months for the account and makes the standard representation that they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Form 144 reports a small, compensation-related sale of 2,500 PSIX shares; disclosure appears routine and compliance-focused.
The notice documents a proposed sale of 2,500 common shares via Morgan Stanley with an aggregate market value of $225,065.75. The shares were acquired through restricted stock vesting on 07/10/2024 and recorded as compensation. Given the reported 23,029,846 shares outstanding and the statement of no sales in the prior three months, this filing reads as a routine insider liquidity event rather than a material corporate development. The inclusion of the standard representation about material non-public information indicates the filer is attesting to compliance with disclosure requirements.
TL;DR: Filing documents a planned sale tied to vested equity; it raises standard governance and compliance considerations but shows no red flags.
The Form 144 shows the securities were acquired from the issuer under a registered plan and are being sold through an institutional broker on the exchange. The filing discloses the acquisition method (restricted stock vesting) and payment nature (compensation), which supports transparency about insider compensation monetization. There are no reported prior sales in the last three months and no stated material undisclosed information, so the disclosure meets routine governance expectations without indicating material adverse events.